About
Neurodegenerative Disease Cell Therapy
NeuroGenesis is a clinical-stage cellular therapy company that focuses on utilizing a proprietary subpopulation of bone marrow stem cells. These cells are specifically selected and enhanced to become remyelinating and regenerative biofactory cells. The company's platform, NG CELL technology, is specifically designed to treat central nervous system diseases, such as progressive multiple sclerosis and amyotrophic lateral sclerosis.
Identity
| Name | Neurogenesis |
|---|---|
| Slug | neurogenesis |
| Type / kind | startup |
| Crunchbase ID | neurogenesis |
| Source _id | Qp3tbzJIjfb0eqlfn2YNJ6GiWqaeEjCwdgjRPDQUkIzY8UFMP8gjyN |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Ramat Gan |
| HQ address | Tuval St 11, Ramat Gan, Israel |
Web & social
| Website | https://neurogenesis-cell.com/ |
|---|---|
| Careers page | https://neurogenesis-cell.com/careers |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesHealthcare
Business models
B2B
Tags
pharmaceuticalscell-therapyamyotrophic-lateral-sclerosis-als
Funding
| Total raised | $6.7M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}